300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Hospitality
Oil and Gas
Film
Retail
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Theatre
Beauty
Medical
Fashion
Infrastructure
Social
Web3
Celebrity
Cannabis
LGBT
Recruiting
Climate
Food and Beverage
Real Estate
Life Science
Publishing
Wine and Spirits
Sporting Goods
Mobile Apps
Finance
Music
Manufacturing
FinTech
Art
Social Media
Franchise
Internet
Android
Mobile Advertising
Impact
Proptech
Hardware
Enterprise
Transportation
Biotech
Sustainability
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Faroe Islands
South Korea
Oceania
Argentina
Hong Kong
Tunisia
Benin
Nigeria
Taiwan
Zimbabwe
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Sudan
Malawi
Isle of Man
Haiti
Iran
Madagascar
Lesotho
Russian Federation
Nepal
Pakistan
Turkey
Liberia
Mexico
Tajikistan
Sweden
Zambia
Romania
Oman
Puerto Rico
Poland
Guernsey
Cameroon
China
Armenia
Costa Rica
Colombia
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Mauritius
Namibia
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
New Zealand
Guatemala
Kazakhstan
Switzerland
Venezuela
Cayman Islands
Myanmar
Uganda
Uruguay
Seychelles
Moldova
Botswana
Paraguay
France
South Africa
Denmark
Ghana
Georgia
Iraq
Philippines
Sierra Leone
Portugal
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Kenya
Latvia
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Bangladesh
Angola
Barbados
Belgium
Europe
Austria
Ethiopia
Cyprus
Jordan
Azerbaijan
Ecuador
Bulgaria
Qatar
Bahamas
Bolivia
Bahrain
Belize
Estonia
Algeria
Jersey
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Iceland
Liechtenstein
Cambodia
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database

Joe Beverly

Angel Investor

Joe Beverly is a pre-seed investor focused on Medical and Marketing. Joe Beverly

Total investments:
3
Last investment:
Lead investor:
100%

Last updated:

Industries Joe Beverly invests in

MedicalMarketingAdvertisingHealth CareLife Science

Stages Joe Beverly invests in

Pre-SeedSeries A

Countries Joe Beverly invests in

United States

Contacts

TypeContactValidation
Work email
Personal email
Work phone
Personal phone
Socials

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Medical 1 (33%)
  • Marketing 1 (33%)
  • Advertising 1 (33%)
  • Health Care 1 (33%)
  • Life Science 1 (33%)
See all 9 industries →

Stage

  • Pre-Seed 2 (67%)
  • Series A 1 (33%)

Investments

CompanyDescriptionRoundLinks
Lasarrus Lasarrus
Lasarrus develops devices for patients with chronic obstructive pulmonary disease. The company was founded in 2018 (incorporated in 2021) and is headquartered in Baltimore, Maryland. $100K / Pre-Seed / Oct 03, 2022
MooveGuru MooveGuru
MooveGuru focuses on consumers to the merchant they need when they need it. The company's services offer just-in-time delivery through artificial intelligence algorithms, enabling consumers to receive agent-branded savings from national and local retailers as they step through the relocation process. $2.3M / Series A / Oct 30, 2019
Lena Biosciences Lena Biosciences
Lena Biosciences is a biotechnology company offering advanced, organ-on-a-chip and 3D cell culture products for precision therapies, biomedical research and drug testing. Its new PerfusionPal product is a high-throughput organ-on-a-chip insert system that yields up to 5 times greater drug metabolism. It fits into existing workflows and enablescustomers to emulate multiple organs, deliver and test drugs in a standard format for ADME Tox screening, cancer research, and precision therapies. Owing to concentrated secretome and metabolome, PerfusionPal is ideally suited for testing slow-to-metabolize drugs and biologics (monoclonal antibodies and antibody-drug conjugates). Pre-Seed / Oct 11, 2016

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Hospitality
Oil and Gas
Film
Retail
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Theatre
Beauty
Medical
Fashion
Infrastructure
Social
Web3
Celebrity
Cannabis
LGBT
Recruiting
Climate
Food and Beverage
Real Estate
Life Science
Publishing
Wine and Spirits
Sporting Goods
Mobile Apps
Finance
Music
Manufacturing
FinTech
Art
Social Media
Franchise
Internet
Android
Mobile Advertising
Impact
Proptech
Hardware
Enterprise
Transportation
Biotech
Sustainability
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Faroe Islands
South Korea
Oceania
Argentina
Hong Kong
Tunisia
Benin
Nigeria
Taiwan
Zimbabwe
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Sudan
Malawi
Isle of Man
Haiti
Iran
Madagascar
Lesotho
Russian Federation
Nepal
Pakistan
Turkey
Liberia
Mexico
Tajikistan
Sweden
Zambia
Romania
Oman
Puerto Rico
Poland
Guernsey
Cameroon
China
Armenia
Costa Rica
Colombia
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Mauritius
Namibia
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
New Zealand
Guatemala
Kazakhstan
Switzerland
Venezuela
Cayman Islands
Myanmar
Uganda
Uruguay
Seychelles
Moldova
Botswana
Paraguay
France
South Africa
Denmark
Ghana
Georgia
Iraq
Philippines
Sierra Leone
Portugal
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Kenya
Latvia
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Bangladesh
Angola
Barbados
Belgium
Europe
Austria
Ethiopia
Cyprus
Jordan
Azerbaijan
Ecuador
Bulgaria
Qatar
Bahamas
Bolivia
Bahrain
Belize
Estonia
Algeria
Jersey
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Iceland
Liechtenstein
Cambodia
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Joe Beverly invest in?

Joe Beverly invests primarily in Medical, Marketing and Advertising startups, most often at Pre-Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Joe Beverly?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

When did Joe Beverly last invest?

The most recent investment recorded for Joe Beverly closed in Oct 2022. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Joe Beverly Find email